These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 11125025)

  • 1. Competitive and allosteric interactions in ligand binding to P-glycoprotein as observed on an immobilized P-glycoprotein liquid chromatographic stationary phase.
    Lu L; Leonessa F; Clarke R; Wainer IW
    Mol Pharmacol; 2001 Jan; 59(1):62-8. PubMed ID: 11125025
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of an immobilized P-glycoprotein stationary phase for on-line liquid chromatographic determination of drug-binding affinities.
    Zhang Y; Leonessa F; Clarke R; Wainer IW
    J Chromatogr B Biomed Sci Appl; 2000 Feb; 739(1):33-7. PubMed ID: 10744311
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The enantioselective binding of mefloquine enantiomers to P-glycoprotein determined using an immobilized P-glycoprotein liquid chromatographic stationary phase.
    Lu L; Leonessa F; Baynham MT; Clarke R; Gimenez F; Pham YT; Roux F; Wainer IW
    Pharm Res; 2001 Sep; 18(9):1327-30. PubMed ID: 11683248
    [No Abstract]   [Full Text] [Related]  

  • 4. Functional studies of P-glycoprotein in inside-out plasma membrane vesicles derived from murine erythroleukemia cells overexpressing MDR 3. Properties and kinetics of the interaction of vinblastine with P-glycoprotein and evidence for its active mediated transport.
    Schlemmer SR; Sirotnak FM
    J Biol Chem; 1994 Dec; 269(49):31059-66. PubMed ID: 7983045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dexniguldipine-HCl is a potent allosteric inhibitor of [3H]vinblastine binding to P-glycoprotein of CCRF ADR 5000 cells.
    Malkhandi J; Ferry DR; Boer R; Gekeler V; Ise W; Kerr DJ
    Eur J Pharmacol; 1994 Dec; 288(1):105-14. PubMed ID: 7705462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and characterization of an open tubular column containing immobilized P-glycoprotein for rapid on-line screening for P-glycoprotein substrates.
    Moaddel R; Bullock PL; Wainer IW
    J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Jan; 799(2):255-63. PubMed ID: 14670744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immobilized receptor- and transporter-based liquid chromatographic phases for on-line pharmacological and biochemical studies: a mini-review.
    Moaddel R; Lu L; Baynham M; Wainer IW
    J Chromatogr B Analyt Technol Biomed Life Sci; 2002 Feb; 768(1):41-53. PubMed ID: 11939557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of modulators on the ATPase activity and vanadate nucleotide trapping of human P-glycoprotein.
    Shepard RL; Winter MA; Hsaio SC; Pearce HL; Beck WT; Dantzig AH
    Biochem Pharmacol; 1998 Sep; 56(6):719-27. PubMed ID: 9751076
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional characterization of a glycine 185-to-valine substitution in human P-glycoprotein by using a vaccinia-based transient expression system.
    Ramachandra M; Ambudkar SV; Gottesman MM; Pastan I; Hrycyna CA
    Mol Biol Cell; 1996 Oct; 7(10):1485-98. PubMed ID: 8898356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conformational mobility of immobilized proteins.
    Moaddel R; Wainer IW
    J Pharm Biomed Anal; 2007 Jan; 43(2):399-406. PubMed ID: 17095178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allosteric modulation of human P-glycoprotein. Inhibition of transport by preventing substrate translocation and dissociation.
    Maki N; Hafkemeyer P; Dey S
    J Biol Chem; 2003 May; 278(20):18132-9. PubMed ID: 12642584
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Allosteric regulation of [3H]vinblastine binding to P-glycoprotein of MCF-7 ADR cells by dexniguldipine.
    Ferry DR; Malkhandi PJ; Russell MA; Kerr DJ
    Biochem Pharmacol; 1995 Jun; 49(12):1851-61. PubMed ID: 7598747
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of initial vinblastine influx by P-glycoprotein.
    Shalinsky DR; Jekunen AP; Alcaraz JE; Christen RD; Kim S; Khatibi S; Howell SB
    Br J Cancer; 1993 Jan; 67(1):30-6. PubMed ID: 8094005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered pharmacokinetics of vinblastine in Mdr1a P-glycoprotein-deficient Mice.
    van Asperen J; Schinkel AH; Beijnen JH; Nooijen WJ; Borst P; van Tellingen O
    J Natl Cancer Inst; 1996 Jul; 88(14):994-9. PubMed ID: 8667431
    [TBL] [Abstract][Full Text] [Related]  

  • 15. P-glycoprotein-mediated multidrug resistance is modulated by pretreatment with chemosensitizers in HCT-8 carcinoma cells in vitro.
    Haberl I; Swatonek H; Schaufler K; Ulsperger E; Wenzl E; Theyer G; Hamilton G; Thalhammer T
    Int J Oncol; 1998 May; 12(5):1137-42. PubMed ID: 9538140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased uptake of cyclosporin A by P-glycoprotein (Pgp) expressing CEM leukemic cells and restoration of normal retention by Pgp blockers.
    Didier A; Wenger J; Loor F
    Anticancer Drugs; 1995 Oct; 6(5):669-80. PubMed ID: 8845477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dissection of drug-binding-induced conformational changes in P-glycoprotein.
    Wang G; Pincheira R; Zhang JT
    Eur J Biochem; 1998 Jul; 255(2):383-90. PubMed ID: 9716379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Enhancement of cytotoxic effect of anticancer agents of renal cell carcinoma].
    Okano M; Kawamoto S; Nezasa S; Tamaki M; Ehara H; Yamada S; Deguchi T; Kawada Y
    Nihon Hinyokika Gakkai Zasshi; 1996 Aug; 87(8):1041-7. PubMed ID: 8831211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simple purification of highly active biotinylated P-glycoprotein: enantiomer-specific modulation of drug-stimulated ATPase activity.
    Julien M; Kajiji S; Kaback RH; Gros P
    Biochemistry; 2000 Jan; 39(1):75-85. PubMed ID: 10625481
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multidrug resistance transporter P-glycoprotein has distinct but interacting binding sites for cytotoxic drugs and reversing agents.
    Pascaud C; Garrigos M; Orlowski S
    Biochem J; 1998 Jul; 333 ( Pt 2)(Pt 2):351-8. PubMed ID: 9657975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.